Please login to the form below

Not currently logged in
Email:
Password:

Celgene name Gerald F. Masoudi as executive VP

Will take up the role of executive VP, general counsel and corporate secretary

Celgene Gerald MasoudiCelgene has named Gerald F. Masoudi as its executive VP, general counsel and corporate secretary, effective from June 1.

Masoudi succeeds Lawrence V. Stein, who is to retire after holding the role since 2012. He will be responsible for global legal strategy and will additionally serve on the company's executive committee.

Robert J. Hugin, chairman and CEO of Celgene, commented: “Larry Stein has served as a valued member of Celgene's senior leadership team and provided the company important strategic legal counsel. 

“Jerry brings a wealth of experience to Celgene. His deep understanding of regulatory policy and his significant healthcare-related legal expertise will add valuable perspective to our leadership team.”

Masoudi joins Celgene from international law firm Covington & Burling, where he is a partner and serves as co-chair of the food and drug practice group. At the company, he has advised multinational companies and trade associations on litigation, enforcement regulatory and public policy matters.

Prior to joining Covington, Masoudi served as chief counsel of the US FDA.

9th April 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics